Tuberculosis news from FierceHealthcare
News
Study: Number of drug-resistant germs rising
Here's an unsettling statistic, to say the least. According to the National Institute of Allergy and Infectious Diseases, the number of germs resistant to antibiotics is growing. The Institute, Read more...
ALSO NOTED: States sue Abbott, claiming it blocked generics; SEC helps troubled hospital bond holders; and much more...
> Eighteen states are suing Abbott Laboratories, saying it blocked generic competition for its popular cholesterol medication TriCor. Read more...
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies